Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor.

Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, König H, Weg-Remers S, Ponta H.

Ann N Y Acad Sci. 2000 Jun;910:106-18; discussion 118-20. Review.

PMID:
10911909
2.

Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.

Bai Y, Liu YJ, Wang H, Xu Y, Stamenkovic I, Yu Q.

Oncogene. 2007 Feb 8;26(6):836-50. Epub 2006 Sep 4.

PMID:
16953231
3.

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P.

Genes Dev. 2001 Apr 15;15(8):968-80.

4.

Expression of CD44 splice variants in spontaneous murine tumors.

Sanchez Lockhart M, Cabrera P, Diament M, Alvarez E, Klein D, Hajos SE.

Int J Mol Med. 2001 May;7(5):557-62.

PMID:
11295121
5.

Distribution and expression of CD44 isoforms and Ezrin during prostate cancer-endothelium interaction.

Harrison GM, Davies G, Martin TA, Jiang WG, Mason MD.

Int J Oncol. 2002 Nov;21(5):935-40.

PMID:
12370738
7.

The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.

Harrison GM, Davies G, Martin TA, Mason MD, Jiang WG.

Oncol Rep. 2006 Jan;15(1):199-206.

PMID:
16328056
8.
9.
10.

The role of the CD44/ezrin complex in cancer metastasis.

Martin TA, Harrison G, Mansel RE, Jiang WG.

Crit Rev Oncol Hematol. 2003 May;46(2):165-86. Review.

PMID:
12711360
11.

The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis.

Lara-Pezzi E, Serrador JM, Montoya MC, Zamora D, Yáñez-Mó M, Carretero M, Furthmayr H, Sánchez-Madrid F, López-Cabrera M.

Hepatology. 2001 May;33(5):1270-81.

PMID:
11343256
12.
13.

Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.

Kuniyasu H, Oue N, Tsutsumi M, Tahara E, Yasui W.

Clin Cancer Res. 2001 Dec;7(12):4067-72.

14.

Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells.

Brown KL, Birkenhead D, Lai JC, Li L, Li R, Johnson P.

Exp Cell Res. 2005 Feb 15;303(2):400-14.

PMID:
15652352
15.

CD44 as a marker in human cancers.

Sy MS, Mori H, Liu D.

Curr Opin Oncol. 1997 Jan;9(1):108-12. Review.

PMID:
9090502
17.

Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation.

Sun CX, Robb VA, Gutmann DH.

J Cell Sci. 2002 Nov 1;115(Pt 21):3991-4000. Review.

18.

Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.

Golshani R, Lopez L, Estrella V, Kramer M, Iida N, Lokeshwar VB.

Cancer Res. 2008 Jan 15;68(2):483-91. doi: 10.1158/0008-5472.CAN-07-2140.

19.

Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.

Huang CS, Shen CY, Wang HW, Wu PE, Cheng CW.

Clin Chim Acta. 2007 Sep;384(1-2):69-74. Epub 2007 Jun 15.

PMID:
17651715
20.

TNFalpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells.

Barshishat M, Ariel A, Cahalon L, Chowers Y, Lider O, Schwartz B.

Clin Exp Metastasis. 2002;19(4):327-37.

PMID:
12090473

Supplemental Content

Support Center